These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12031658)

  • 1. ZymoGenetics. A quiet powerhouse emerges.
    Frederickson RM
    Chem Biol; 2002 May; 9(5):533-4. PubMed ID: 12031658
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative design for improved therapeutic proteins.
    Desjarlais JR; Lazar GA
    Trends Biotechnol; 2003 Oct; 21(10):425-7. PubMed ID: 14512227
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioinformatics, target discovery and the pharmaceutical/biotechnology industry.
    Fagan R; Swindells M
    Curr Opin Mol Ther; 2000 Dec; 2(6):655-61. PubMed ID: 11249743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good science doesn't guarantee good drugs.
    Siegel J
    Biotechnology (N Y); 1995 Jan; 13(1):13. PubMed ID: 9678905
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural genomics in the biotechnology sector.
    Dry S; McCarthy S; Harris T
    Nat Struct Biol; 2000 Nov; 7 Suppl():946-9. PubMed ID: 11103995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The end of the beginning for genomic medicine.
    Bailey D; Zanders E; Dean P
    Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
    [No Abstract]   [Full Text] [Related]  

  • 8. Sugar added. Cheaper, better protein drugs through sweetening.
    Gibbs W
    Sci Am; 2003 Jul; 289(1):23-4. PubMed ID: 12840940
    [No Abstract]   [Full Text] [Related]  

  • 9. Mining the genome for drugs.
    Wickelgren I
    Science; 1999 Aug; 285(5430):998-1001. PubMed ID: 10475849
    [No Abstract]   [Full Text] [Related]  

  • 10. Design of site-specific protein drugs.
    Tomlinson E
    Sci Total Environ; 1991 Dec; 109-110():9-16. PubMed ID: 1815386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics in the pharmaceutical industry.
    Lyall A
    Trends Biotechnol; 1996 Aug; 14(8):308-12. PubMed ID: 8987464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 13. New clot busters threaten Genentech's tPA.
    Davidson S
    Nat Biotechnol; 1997 May; 15(5):405. PubMed ID: 9131608
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical biotechnology emerges in Mexico.
    Ramirez OT; Quintero R
    Nat Biotechnol; 1999 Oct; 17(10):934. PubMed ID: 10504675
    [No Abstract]   [Full Text] [Related]  

  • 15. The changing face of bioinformatics.
    Gatto JG
    Drug Discov Today; 2003 May; 8(9):375-6. PubMed ID: 12706646
    [No Abstract]   [Full Text] [Related]  

  • 16. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 17. ZymoGenetics' moves recall young Genentech.
    Kling J
    Nat Biotechnol; 2007 Sep; 25(9):955. PubMed ID: 17846611
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant proteins for medical use: the attractions and challenges.
    Koths K
    Curr Opin Biotechnol; 1995 Dec; 6(6):681-7. PubMed ID: 8527840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approval times for supplemental indications for recombinant proteins.
    Gosse ME; Nelson TF
    Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135
    [No Abstract]   [Full Text] [Related]  

  • 20. Information needs and the role of text mining in drug development.
    Roberts PM; Hayes WS
    Pac Symp Biocomput; 2008; ():592-603. PubMed ID: 18229718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.